Key facts
- It has raised $710K; the latest was Seed Round ($710K) in Nov 2025.
- Notable investors include Mana Ventures, Boost VC, CREATE-X, CreationsVC.
- Status: Privately Held (backing).
Investors
4- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Deleon
- ·The full record, as it builds
Funding rounds
No funding rounds for Deleon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Deleon
Operator of portable biochemical analysis technology designed for real-time human performance and wellness monitoring. The company captures metabolomic signals from a urine sample and transforms raw analyses into personalised recommendations on sleep, nutrition, and training through a unified dashboard, enabling clinical, athletic, and operational markets to make rapid, individualized decisions without reliance on centralized lab infrastructure.
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Employees
- 4
- Website
- deleon-omics.com/
- Ownership
- Privately Held (backing)
Deleon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Deleon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Deleon in its N-PORT filings yet. We sweep new filings monthly.